XL-0715/900
XL-0715/900
Rated 2.00 out of 5 based on 4 customer ratings
(5 customer reviews)
2.00 out of 5
2.00 out of 5
CLEANING GREASE FOR BEARINGS USING XL-0715/002
XL-0715/900 Is a solvent containing grease designed to loosen and rejuvenate bearings that have
residual or dried XL-0715/002.
XL-0715/900 has been formulated with the same synthetic PAO base oil as the XL0715 to provide
superior lubrication as it cleans bearings.
N.B. Due to the thixotropic and cleansing properties of the XL-0715/900 certain
precautions must be taken not to over lubricate bearings Apply XL-0715/900
with the same equipment used for XL-0715/002. Inspect bearings after
lubricating and observe old grease as it is forced out and determine the
‘cleaning’ cycle. Use only enough XL-0715/900 to
clean bearing then return application toXL-0715/002
TYPICAL SPECIFICATIONS | |
---|---|
Product Code: XL-0715 | /900 |
N.L.G.I. Grade: | 1 – 1.5 |
Dropping Point (°C) (ASTM D-2265) | None |
Melting Point (°C) | None |
Copper Strip Test (163°C for 3 hours) | Negative |
Texture | Soft / Adhesive |
Colour | Yellow |
Timken OK Load (kg) (ASTM D-2509) | 22 |
Type of thickener | Silica |
Oil Separation (24hrs @ 25°C) (ASTM D-1742) | N/A |
Temperature Range (°C) | -17 to 399 |
Minimum Dispensing Temperature (°C) | -1 |
Solvent Type | Trichloroethylene |
Category: HI TEMP GREASE.
Cart
- No products in the cart.
Witaj zwą mnie Janusz. Adwokat Rzeszów jest dostępny również dla Ciebie. W tej chwili moim miejscem przebywania jest cudne miasto Żnin. Adwokat Rzeszów w Polsce- opisanie statystyczne rodzimych pożyczkobiorców.
https://adwokat-rzeszow.biz/
Respiratory viruses such as rhinovirus, adenovirus, and parainfluenza virus have been isolated infrequently by viral culture of sinus aspirates ivermectine 6mg
WhatsApp 971581274826 We also provide free delivery legit cialis online
Tumour lysis syndrome buy clomid and nolvadex online The higher the number of axillary lymph nodes involved, the higher the chance of recurrent disease
cialis cost Schwartz et al 23 observed that approximately equal percentages of breast cancer patients with BRCA1 2 mutations chose bilateral mastectomy and breast conserving surgery as their definitive surgery